03:56 PM EDT, 07/01/2025 (MT Newswires) -- Health care stocks advanced late Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each climbing 1.4%.

The iShares Biotechnology ETF (IBB) added 0.9%.

In corporate news, RedHill Biopharma ( RDHL ) shares rose 5.8% after it said Tuesday it has started patient recruitment for a phase 2 trial of opaganib in combination with darolutamide for the treatment of metastatic castrate-resistant prostate cancer.

AstraZeneca ( AZN ) Chief Executive Pascal Soriot has spoken privately on a number of occasions of his preference to move the company's stock market listing to the US, The Times reported Tuesday. AstraZeneca ( AZN ) gained 2.2%.

IGM Biosciences ( IGMS ) shares jumped 15% after the firm said it has agreed to be acquired by Concentra Biosciences.

Sage Therapeutics ( SAGE ) is cutting 338 jobs, or the majority of its workforce, after the biotech company agreed to be acquired by Supernus Pharmaceuticals ( SUPN ) , according to government filings in Massachusetts and media reports. Sage shares were down 0.2%, and Supernus added 0.9%.